Allos Therapeutics Inc (ALTH)

HEALTH CARE: PHARMACEUTICALS
SIC: PHARMACEUTICAL PREPARATIONS
*** This stock is shown as delisted in our database. *** If you think this isn't correct then please let us know

11080 CIRCLEPOINT ROAD WESTMINSTER, CO 80020

Develops and commercializes innovative small molecule drugs for improving cancer treatments. Lead product candidate is EFAPROXYN (efaproxiral), a synthetic small molecule that has the potential to sensitize hypoxic (oxygen deprived) tumor tissues and enhance the efficacy of radiation therapy.

View SEC Filings from ALTH instead.
Q1 2021 All 13F Filers Prior Change Hedge Funds 1 Prior Change
No data found for this quarter.
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding ALTH (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding ALTH BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

WARBURG PINCUS PRIVATE EQUITY VIII, L.P.

WARBURG PINCUS PARTNERS LLC

WARBURG PINCUS & CO.

WARBURG PINCUS LLC

KAYE CHARLES R

LANDY JOSEPH P.

  • Director
  • 10% Owner
No longer subject to file 2012-09-05 0

SPECTRUM PHARMACEUTICALS INC

SAPPHIRE ACQUISITION SUB, INC.

  • 10% Owner
1,000 2012-09-05 0

SHAH BIMAL R. CFO AND TREASURER

  • Officer
0 2012-09-05 0

OLER ABRAHAM N. PRESIDENT AND SECRETARY

  • Officer
0 2012-09-05 0

BENNETT BRUCE K JR VP, PHARMACEUTICAL OPERATIONS

  • Officer
0 2012-09-04 0

SCHICK MICHAEL E VP, SALES AND MARKETING

  • Officer
No longer subject to file 2012-09-04 0

BERNS PAUL L CHIEF EXECUTIVE OFFICER

  • Officer
No longer subject to file 2012-09-04 0

GOLDSMITH BRUCE A SVP, CORPORATE DEVELOPMENT

  • Officer
No longer subject to file 2012-09-04 0

CLARK DAVID C VP, FINANCE

  • Officer
No longer subject to file 2012-09-04 0

GRABOYES MARC H SVP, GENERAL COUNSEL

  • Officer
No longer subject to file 2012-09-04 0

MORRIS CHARLES Q CHIEF MEDICAL OFFICER

  • Officer
No longer subject to file 2012-09-04 0

LEFF JONATHAN S

  • Director
No longer subject to file 2012-09-04 0

HOFFMAN STEPHEN J

  • Director
No longer subject to file 2012-09-04 0

STOUT DAVID M

  • Director
No longer subject to file 2012-09-04 0

LATTS JEFFREY

  • Director
No longer subject to file 2012-09-04 0

GONZALO CECILIA

  • Director
No longer subject to file 2012-09-04 0

TURNER JOSEPH L

  • Director
No longer subject to file 2012-09-04 0

DESILVA NISHAN M

  • Director
35,000 2011-12-13 0

LYNCH TIMOTHY P

  • Director
No longer subject to file 2011-08-18 0

HEN STEWART

  • Director
No longer subject to file 2010-06-22 0

CARUSO JAMES V CHIEF COMMERCIAL OFFICER

  • Officer
103,659 2010-03-01 0

CAGNONI PABLO J SR. VP, CHIEF MEDICAL OFFICER

  • Officer
No longer subject to file 2009-09-30 0

CASEY MICHAEL D

  • Director
0 2009-06-23 0

BAKER BROTHERS LIFE SCIENCES CAPITAL (GP), LLC

BAKER JULIAN

BAKER FELIX

  • 10% Owner
No longer subject to file 2009-02-04 0

BAKER BIOTECH CAPITAL (GP), LLC

BAKER JULIAN

BAKER FELIX

  • 10% Owner
No longer subject to file 2009-02-04 0

BAKER / TISCH CAPITAL (GP), LLC

BAKER JULIAN

BAKER FELIX

  • 10% Owner
No longer subject to file 2009-02-04 0

14159 CAPITAL (GP), LLC

BAKER JULIAN

BAKER FELIX

  • 10% Owner
No longer subject to file 2009-02-04 0

BAKER BROS. CAPITAL (GP), LLC

BAKER JULIAN

BAKER FELIX

  • 10% Owner
No longer subject to file 2009-02-04 0

BAKER JULIAN

BAKER FELIX

  • 10% Owner
No longer subject to file 2009-02-04 0

WARBURG PINCUS PRIVATE EQUITY VIII L P

  • Director
  • 10% Owner
26,124,430 2008-05-29 0

JOHNSON DOUGLAS G VP OF MANUFACTURING

  • Officer
32,467 2008-01-07 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
No current insider transactions

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

Elevate your investments